Showing results (111-120 of 4,902) with videos related to
Sort By:
Pageof 491
Cancer Surveys|January 1, 1992
T cell recognition of Epstein-Barr virus associated lymphomasA B Rickinson, R J Murray, J Brooks, et al.Cellular Immunology|April 15, 1990
Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformantsS R Burrows, I S Misko, T B Sculley, et al.The Journal of General Virology|September 1, 1994
Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3S R Burrows, J Gardner, R Khanna, et al.British Journal of Cancer|January 1, 1997
Familial Burkitt's lymphoma in Papua New GuineaA Winnett, S J Thomas, B J Brabin, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1993
Peptide epitope induced apoptosis of human cytotoxic T lymphocytes. Implications for peripheral T cell deletion and peptide vaccinationA Suhrbier, S R Burrows, A Fernan, et al.Nature|February 25, 1988
Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformantsD J Moss, I S Misko, S R Burrows, et al.International Journal of Cancer|April 1, 1991
Prognostic significance of monoclonal antibody 3H-1 reactivity with squamous-cell head-and-neck cancersJ H Kearsley, J H Leonard, H Takahashi, et al.Optics Express|April 15, 2010
Error-free all-optical demultiplexing at 160Gb/s via FWM in a silicon nanowireF Li, M Pelusi, D-X Xu, et al.Immunity|June 10, 1998
HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loadingC A Peh, S R Burrows, M Barnden, et al.International Immunology|November 14, 1997
Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processingR Khanna, S R Burrows, P M Steigerwald-Mullen, et al.Pageof 491